Hydroa vacciniforme

1. Bazin E. Lesions theoriques et cliniques sur les affectations generiques de la peau. Vol. I. Paris, 1862: 132 (cit. Harber LC, Bickers DR. Hydroa aestivale and hydroa vacciniforme. In: Photosensitivity Diseases. 2nd ed. Toronto: DC Decker, 1989: 235–240).

2. Mendoza N, Diamantis M, Bartlett B, et al. Mucocutaneous manifestations of Epstein-Barr virus infection. Am. J. Clin. Dermatol. 2008; 3: 295−305.

3. Ericson LA. Polymorphous light reaction and chronic photosensitivity. Pathol. Internat. 2004; 54 (Suppl 1): S559–S569.

4. Magnus IA. Hydroa vacciniforme. In: Dermatological Photobiology. Oxford: Blackwell,1976: 189−190.

5. Wierzbicka E, Malthieu F, Villers A, et al. Oral involvement in hydroa vacciniforme. Arch. Dermatol. 2006; 5: 651.

6. Bennion SD, Johnson C ,Weston WL. Hydroa vacciniforme with inflammatory keratitis and secondary anterior uveitis. Pediatr. Dermatol. 1987; 4: 320−324.

7. Lim HW, Epstein J. Photosensitivity diseases. J. Am. Acad. Dermatol. 1997; 36: 84−90.

8. Halasz CLG, Leach EE, Walther RR, et al. Hydroa vacciniforme: induction of lesions with ultraviolet A. J. Am. Acad. Dermatol. 1983; 8: 171−176.

9. Bickers DR, Demar LK, DeLeo E, et al. Hydroa vacciniforme. Arch. Dermatol. 1978; 114: 1193−1196.

10. Lehmann P, Neumann N. Photodiagnostische Testverfahren bei Patienten mit Verdacht auf Photodermatosen. In: Licht und Haut. Münster: Biermann, 1993: 92.

11. Jaschke E, Hönigsmann H. Hydroa vacciniforme − Aktionspektrum. UV-Toleranz nach Photochemotherapie. Hautarzt 1981; 32: 350.

12. Galosi A, Plewig J, Ring J, et al. Experimentelle Auslösung von Hauterscheinungen bei Hydroa vacciniformia. Hautarzt 1985; 36: 449−452.

13. Roelandts R. The diagnosis of photosensitivity. Arch. Dermatol. 2000; 136: 1152−1157.

14. Megahed M, Schaller J. Histopathologie der Photodermatosen. Hautarzt 2006; 57: 1083−1088.

15. Morizane S, Suzuki D, Tsuji K, et al. The role of CD4 and CD8 cytotoxic lymphocytes in the formation of viral vesicles. Br. J. Dermatol. 2005; 153: 981−986.

16. Malina L. Hydroa vacciniforme. In: Fotodermatózy. 2. vyd. Praha: Maxdorf, 2005: 68−70, 186.

17. Braun-Falco O, Plewig G, Wolff HH. In: Dermatologie und Venereologie. 4. vyd. Bratislava: Osveta, 1996: 455.

18. Tanew A, Maier H. Photo- und Photochemotherapie von Photodermatosen. In: Krutmann J, Hönigsmann H. Handbuch der Dermatologischen Phototherapie und Photodiagnostik. Berlin: Springer, 1997: 88−89.

19. Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventive treatment for the photodermatoses. Br. J. Dermatol. 1995; 132: 956−963.

20. Goldgeiger MH, Nordlund JJ, Lucky AW, et al. Hydroa vacciniforme: diagnosis and therapy. Arch. Dermatol. 1982; 118: 588−591.

21. Iwatsuki K, Xu Z-G, Takata M, et al. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br. J. Dermatol. 1999; 140:715−721.

22. Gupta G, Man I, Kemmet D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J. Am. Acad. Dermatol. 2000; 42: 208−213.

23. Sawada A, Sato E, Koyama M, et al. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymfoproliferative disease and evaluating the treatment effect. Am. J. Hematol. 2006; 81: 576−581.

24. Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch. Dermatol. 2006; 142: 587−595.